# Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

> **NCT07039318** · PHASE2 · COMPLETED · sponsor: **National Institute of Blood and Marrow Transplant (NIBMT), Pakistan** · enrollment: 78 (actual)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells
- **DRUG:** Normal Saline (Placebo)

## Key facts

- **NCT ID:** NCT07039318
- **Lead sponsor:** National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-05-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039318, "Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07039318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*